Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 13, 2012
Previous Article Next Article

In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Author affiliations

Abstract

The human immunodeficiency virus (HIV) causes AIDS (acquired immune deficiency syndrome), a disease in which the immune system progressively deteriorates, making sufferers vulnerable to all manner of opportunistic infections. Currently, world-wide there are estimated to be 34 million people living with HIV, with the vast majority of these living in sub-Saharan Africa. Therefore, an important research focus is development of new drugs that can be used in the treatment of HIV/AIDS. This review gives an overview of the disease and addresses the drugs currently used for treatment, with specific emphasis on new developments within the class of allosteric non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Graphical abstract: In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 29 Feb 2012 and first published on 22 May 2012


Article type: Tutorial Review
DOI: 10.1039/C2CS35058K
Citation: Chem. Soc. Rev., 2012,41, 4657-4670
  •   Request permissions

    In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)

    C. Reynolds, C. B. de Koning, S. C. Pelly, W. A. L. van Otterlo and M. L. Bode, Chem. Soc. Rev., 2012, 41, 4657
    DOI: 10.1039/C2CS35058K

Search articles by author